2017 Endocrine Board Review Course

Chicago, IL US

Welcome to the Endocrine Board Review 2017 live course Evaluation

Unlike other board preparation meetings, the Endocrine Society's Board Review Course offers a comprehensive mock-exam format, with case-based ABIM-style questions forming the bulk of the presentations. Each section follows the ABIM blueprint for the board exam, covering the breadth and depth of the certification/recertification examination. But you won't just get a right or wrong answer—each case will be discussed in detail, with the correct and incorrect answer options reviewed. You'll also have opportunities to ask questions directly to the faculty, and review detailed answer explanations, references, and a customized score report.

Learning Objectives

Upon completion of this educational activity, learners will be able to demonstrate enhanced medical knowledge and clinical skills across all major areas of endocrinology; apply knowledge and skills in diagnosing, managing, and treating a wide spectrum of endocrine disorders; and successfully complete the board examination for certification or recertification in the subspecialty of endocrinology, diabetes, and metabolism.

Additional Information

Target Audience: 
Clinical researcher
Scientific researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Systems-based Practice
Topic Area: 
Adrenal/HPA Axis
Bone and Calciotropic Hormones
Diabetes and Glucose Metabolism
Lipid Disorders and Fatty Liver Diseases
General Endocrinology
Hormone Abuse
Growth Disorders
Health Disparities
Hormones and Cancer
Men’s Health
Neuroendocrinology and Pituitary
Thyroid/HPT Axis
Women’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Level 4 (Learning: Competence (Shows How))
Activity summary
Available credit: 
  • 14.25 ABIM MOC
  • 14.25 AMA PRA Category 1 Credits
  • 14.25 CME Certificate of Participation
Course opens: 
Course expires: 

Day One – Tuesday, September 26, 2017

7:00–8:00 AMContinental Breakfast
8:00–8:15 AMWelcome and Overview of the Certification Process
David S. Cooper, MD
8:15–9:45 AM

Diabetes Board Review
Serge Jabbour, MD

9:45–10:00 AMQ&A with Dr. Jabbour
10:15–11:30 AMAdrenal Board Review 
Richard Auchus, MD, PhD
11:30–11:45 AMQ&A with Dr. Auchus
12:45–2:15 PMCalcium and Bone Board Review
Carolyn Becker, MD
2:15–2:30 PMQ&A with Dr. Becker
2:45–4:15 PMObesity/Lipids Board Review
Andrea Coviello, MD
4:15–4:30 PMQ&A with Dr. Coviello
4:30–4:45 PMWrap-up

Day Two – Wednesday, September 27, 2017

7:00–8:00 AMContinental Breakfast
8:00–9:15 AMPituitary Board Review
Mark Molitch, MD
9:15–9:30 AMBREAK
9:30–11:15 AMDiabetes Board Review, continued
Michelle Magee, MD
11:15–11:30 AMQ&A with Dr. Magee
11:30 AM–12:30 PMLUNCH
12:30–1:30 PMFemale Reproduction Board Review
Margaret Wierman, MD
1:30–1:45 PMQ&A with Dr. Wierman
1:45–2:45 PMMale Reproduction Board Review 
Frances Hayes, MD
2:45–3:00 PMQ&A with Dr. Hayes
3:00–3:15 PMBREAK
3:15–4:45 PMThyroid Board Review 
Elizabeth Pearce, MD
4:45–5:00 PMQ&A with Dr. Pearce
5:00–5:15 PMWrap-up
Chicago Marriott Downtown
540 N Michigan Ave
Chicago, IL 60611
United States

Endocrine Board Review Chair
David S. Cooper, MD – The Johns Hopkins University School of Medicine

Faculty Authors
Richard J. Auchus, MD, PhD – University of Michigan
Carolyn B. Becker, MD – Brigham and Women’s Hospital
Daniel H. Bessesen, MD – University of Colorado School of Medicine
Andrea D. Coviello, MD – Duke University School of Medicine
Frances J. Hayes, MD – Massachusetts General Hospital
Serge A. Jabbour, MD – Thomas Jefferson University Sidney Kimmel Medical College
Michelle F. Magee, MD – MedStar Washington Hospital Center and Georgetown University School of Medicine
Mark E. Molitch, MD – Northwestern University Feinberg School of Medicine
Elizabeth N. Pearce, MD, MSc – Boston University School of Medicine
Margaret E. Wierman, MD – University of Colorado School of Medicine

Medical Editor  
Abbie L. Young, MS, CGC, ELS(D)

Disclosure Policy

The faculty, committee members, and staff who are in a position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

Richard J. Auchus, MD, PhD: Contracted Research, Millendo Pharmaceuticals, Strongbridge Biopharma, Novartis Pharmaceuticals; Consultant, Alder Biopharmaceuticals, Corcept Pharmaceuticals, Diurnal Limited, Ipsen Pharmaceuticals, Janssen Pharmaceuticals, Novartis Pharmaceuticals, Spruce Biosciences, Strongbridge Biopharma

Andrea D. Coviello, MD: Consultant and Speaker, Novo Nordisk Inc.

Serge A. Jabbour, MD: Consultant, AstraZeneca, Eli Lilly & Co., Janssen Pharmaceuticals

Mark E. Molitch, MD: Consultant, Pfizer Inc.; Consultant and Primary Investigator, Chiasma, Inc., Ipsen Pharmaceuticals, Novartis Pharmaceuticals

Elizabeth N. Pearce, MD, Msc: Primary Investigator, Sociedad Química y Minera de Chile S.A.; Speaker, IBSA Institut Biochimique SA, Merck Serono

The following faculty reported no relevant financial relationships: Carolyn B. Becker, MD; David S. Cooper, MD; Frances J. Hayes, MD; Michelle F. Magee, MD; Margaret E. Wierman, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.


The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.The Endocrine Society designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC):

By attending the 2017 Endocrine Board Review, you are eligible to earn a maximum of 14.25 American Board of Internal Medicine (ABIM) Medical Knowledge MOC points.

In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:

  1. Provide your board-certification information in your educational profile

Review & Edit your Profile


Available Credit

  • 14.25 ABIM MOC
  • 14.25 AMA PRA Category 1 Credits
  • 14.25 CME Certificate of Participation

Click the Start button to go to the evaluation.